Literature DB >> 27086797

Sarcopenia and Sarcopenic Obesity Are Prognostic Factors for Overall Survival in Patients with Cirrhosis.

Nagisa Hara1, Motoh Iwasa, Ryosuke Sugimoto, Rumi Mifuji-Moroka, Kyoko Yoshikawa, Eriko Terasaka, Ayana Hattori, Masumi Ishidome, Yoshinao Kobayashi, Hiroshi Hasegawa, Kazuko Iwata, Yoshiyuki Takei.   

Abstract

OBJECTIVE: Although the prognosis is known to be poor in cirrhosis patients associated with sarcopenia, the relationships among skeletal muscle, visceral fat, and the liver have not yet been thoroughly investigated. Therefore, the prognosis and its associations with body composition and the severity of liver disease were examined in patients with cirrhosis.
METHODS: The skeletal muscle mass and visceral fat area were measured in 161 patients with cirrhosis, the effects of body composition on the prognosis were analyzed, and any factors that contribute to changes in body composition were assessed.
RESULTS: During the mean observation period of 1,005 days, 73 patients died. Patients with sarcopenia or sarcopenic obesity had a poor prognosis, and this difference was pronounced in the subset of patients classified as Child-Pugh class A. A decreased skeletal muscle mass was strongly correlated with decreased serum albumin levels. Sarcopenia is a common feature of advanced cirrhosis, and transitions were observed from normal body composition to sarcopenia and from obese to sarcopenic obesity.
CONCLUSION: The body composition is a prognostic factor for cirrhosis, and a better body composition may be advantageous for obtaining a long-term survival in patients with cirrhosis.

Entities:  

Mesh:

Year:  2016        PMID: 27086797     DOI: 10.2169/internalmedicine.55.5676

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  32 in total

1.  A North American Expert Opinion Statement on Sarcopenia in Liver Transplantation.

Authors:  Elizabeth J Carey; Jennifer C Lai; Christopher Sonnenday; Elliot B Tapper; Puneeta Tandon; Andres Duarte-Rojo; Michael A Dunn; Cynthia Tsien; Eric R Kallwitz; Vicky Ng; Srinivasan Dasarathy; Matthew Kappus; Mustafa R Bashir; Aldo J Montano-Loza
Journal:  Hepatology       Date:  2019-08-19       Impact factor: 17.425

Review 2.  Sarcopenia in Alcoholic Liver Disease: Clinical and Molecular Advances.

Authors:  Jaividhya Dasarathy; Arthur J McCullough; Srinivasan Dasarathy
Journal:  Alcohol Clin Exp Res       Date:  2017-07-11       Impact factor: 3.455

3.  Sarcopenia after induction therapy in childhood acute lymphoblastic leukemia: its clinical significance.

Authors:  Daisuke Suzuki; Ryoji Kobayashi; Hirozumi Sano; Daiki Hori; Kunihiko Kobayashi
Journal:  Int J Hematol       Date:  2017-12-12       Impact factor: 2.490

Review 4.  Implications of pre-transplant sarcopenia and frailty in patients with non-alcoholic steatohepatitis and alcoholic liver disease.

Authors:  Joseph S Redman; Matt Kaspar; Puneet Puri
Journal:  Transl Gastroenterol Hepatol       Date:  2022-07-25

Review 5.  European guideline on obesity care in patients with gastrointestinal and liver diseases - Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline.

Authors:  Stephan C Bischoff; Rocco Barazzoni; Luca Busetto; Marjo Campmans-Kuijpers; Vincenzo Cardinale; Irit Chermesh; Ahad Eshraghian; Haluk Tarik Kani; Wafaa Khannoussi; Laurence Lacaze; Miguel Léon-Sanz; Juan M Mendive; Michael W Müller; Johann Ockenga; Frank Tacke; Anders Thorell; Darija Vranesic Bender; Arved Weimann; Cristina Cuerda
Journal:  United European Gastroenterol J       Date:  2022-08-12       Impact factor: 6.866

Review 6.  Implications of low muscle mass across the continuum of care: a narrative review.

Authors:  Carla M Prado; Sarah A Purcell; Carolyn Alish; Suzette L Pereira; Nicolaas E Deutz; Daren K Heyland; Bret H Goodpaster; Kelly A Tappenden; Steven B Heymsfield
Journal:  Ann Med       Date:  2018-09-12       Impact factor: 4.709

Review 7.  Sarcopenia from mechanism to diagnosis and treatment in liver disease.

Authors:  Srinivasan Dasarathy; Manuela Merli
Journal:  J Hepatol       Date:  2016-08-08       Impact factor: 25.083

8.  Assessment of Body Composition and Dietary Intake in Nursing-Home Residents: Could Lessons Learned from the COVID-19 Pandemic Be Used to Prevent Future Casualties in Older Individuals?

Authors:  Irena Keser; Selma Cvijetić; Ana Ilić; Irena Colić Barić; Dario Boschiero; Jasminka Z Ilich
Journal:  Nutrients       Date:  2021-04-29       Impact factor: 5.717

Review 9.  The Role of Sarcopenic Obesity in Cancer and Cardiovascular Disease: A Synthesis of the Evidence on Pathophysiological Aspects and Clinical Implications.

Authors:  Erika Aparecida Silveira; Rômulo Roosevelt da Silva Filho; Maria Claudia Bernardes Spexoto; Fahimeh Haghighatdoost; Nizal Sarrafzadegan; Cesar de Oliveira
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

10.  Sarcopenia is associated with longer hospital stay and multiorgan dysfunction in alcoholic hepatitis.

Authors:  Yasir Al-Azzawi; Betty Albo; Matthew Fasullo; Jennifer Coukos; George J Watts; Ryan Tai; David Radcliffe; Aimee Kroll-Desrosiers; Deepika Devuni; Gyongyi Szabo
Journal:  Eur J Gastroenterol Hepatol       Date:  2020-06       Impact factor: 2.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.